NCT06652334

Brief Summary

The goal of this observational study is to compare the regional anesthetic methods (not including general anesthesia) -spinal anesthesia, erector spinae plane (ESP) block- which are in routine practice in critically ill adult patients operated for femur fracture, in terms of intraoperative and postoperative hemodynamics and clinical course, postoperative intensive care unit stay and hospitalization durations, pain scores, postoperative morbidity, and mortality. Participants will undergo either spinal anesthesia or erector spinae plane block.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 17, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

October 20, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 22, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

June 3, 2025

Status Verified

June 1, 2025

Enrollment Period

7 months

First QC Date

October 17, 2024

Last Update Submit

June 2, 2025

Conditions

Keywords

Anesthesia, SpinalGeriatric AnesthesiaAnesthesia and AnalgesiaNerve Block

Outcome Measures

Primary Outcomes (6)

  • Pain scores

    The Visual Analog Scale (VAS) is planned to be used for pain scoring. It will assess the severity of patients' pain in the preoperative and postoperative periods. It will be administered using a 10-centimeter line, with the words "no pain" on one side and "most severe pain" on the other. Patients will be asked to place a mark along the line at a level representing the intensity of their pain, which will then be measured in cm. The mark at 0 cm means "no pain," and the mark at 10 cm represents "the most severe pain the patient has ever sensed." Higher VAS scores mean the worst outcome. The patients' VAS scores will be evaluated preoperatively, at 1 hour, 6 hours, 12 hours, and 24 hours postoperatively.

    The VAS scores of the patients will be evaluated preoperatively, at 1 hour, 6 hours, 12 hours and 24 hours postoperatively.

  • Intraoperative sedation

    The total dose of sedatives used along the operation to maintain a BIS value between 80-90.

    The total dose of sedatives used along the operation will be calculated one time immediately at the end of the operation

  • Intensive care unit length of stay

    Time from end of the operation to discharge of the intensive care unit

    Through study completion, an average of 24 months.The intensive care unit length of stay will be calculated one time at the end of the intensive care unit stay, immediately at the timepoint of intensive care unit discharge.

  • Hospital length of stay

    Time from discharge of the intensive care unit to discharge of the hospital

    Through study completion, an average of 24 months.The ihospital length of stay will be calculated one time at the end of the hospital stay, immediately at the timepoint of the hospital discharge.

  • Complications in the Intensive Care Unit

    Clinical course - if any need for noninvasive/invasive mechanical ventilation, need for oxygen support, need for inotropes, development of acute kidney injury, state of consciousness, or additional complications- will be monitored and recorded at ICU (Intensive Care Unit).

    Complications will be recorded 1 time per day along the intensive care unit stay up to 90th day postoperatively.

  • Mortality

    In-hospital mortality, Intensive care mortality and Mortality after discharge. Patients will be followed up by telephone contact for mortality on the 30th and 90th postoperative days after discharge.

    Mortality will be recorded 4 times up to 90th day postoperatively.: 1- at the time of discharge from the Intensive care unit, 2-at the time of discharge from the hospital 3- on the postoperative 30th day, 4- Mortality on the postoperative90th day

Study Arms (2)

Spinal anesthesia

20 patients undergoing spinal anesthesia

Procedure: Spinal anesthesia

Erector spinae plane block

20 patients undergoing erector spinae plane block

Procedure: Erector spinae plane block

Interventions

20 patients undergoing spinal anesthesia

Spinal anesthesia

20 patients undergoing erector spinae plane block

Erector spinae plane block

Eligibility Criteria

Age65 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

After the patients who meet the specified criteria are informed about the study, 40 volunteers who agree to participate and sign an informed consent form will be included in the study. Volunteers will be randomized into 2 groups using a closed-envelope method. Group 1 will contain patients operated under spinal anesthesia, and Group 2 will contain patients operated under ESP block.

You may qualify if:

  • Agree to participate in the study
  • Patients older than 65 years of age who are planning to undergo an operation for a femur fracture and who are in the ASA III and above risk group and for whom postoperative intensive care unit follow-up is foreseen
  • Patients who agree to be operated under regional anesthesia

You may not qualify if:

  • Patients who did not want to be included in the study
  • Patients considered suitable for operation under general anesthesia
  • Patients allergic to bupivacaine
  • Patients with contraindications to neuraxial blockage (infection at the injection site, coagulopathy or other bleeding diathesis, severe hypovolemia, increased intracranial pressure, severe aortic stenosis, severe mitral stenosis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duzce University Faculty of Medicine

Düzce, Düzce, 81000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Femoral FracturesAgnosia

Interventions

Anesthesia, Spinal

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesLeg InjuriesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Officials

  • Özlem Ersoy Karka, Ass. Prof.

    Düzce University Faculty of Medicine

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 17, 2024

First Posted

October 22, 2024

Study Start

October 20, 2024

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

June 3, 2025

Record last verified: 2025-06

Locations